Types of Inventions That Are Patentable
How can OSS Negatively Affect a Company?
Helping In-House Council
5 Year View Point
First Step in Performing a Patent Portfolio Audit
Unlicensed Source Codes
What is a Patent?
Attorneys and Patent Profile Analytics
Patent Citation Ranking
Moderate Risk Joint Ventures
Limited Valuable Patents in Technology Area
Patents and Other Forms of Intellectual Property Protection
Golden Rule of Auditing a Patent Portfolio
Cost/Value Curve of Patent a Portfolio
Meet Mark Stignani
Rewards of the Practice
Factors That Cause a Patent to Decline in Value
Benefits of Audit Action Sheet
Practicing an Invention
Common Reasons Trademarks Are Rejected
Post-Grant Proceedings and Patent Enforcement
How Do Patent Portfolio Values Become Concentrated over Time?
How Does the Knowledge Gap Develop?
Provisional vs Non-Provisional Patent
Demonstrating BioSimilarity Under U.S. Law
Cost/Value Curve of a High Level Patent
What is an Invention?
Standard for Getting a Patent
"Who" - Audit Action Sheet
Inter Partes Review
Value Management and Cash Flow
Importance of Freedom To Operate
When to Do a Freedom to Operate
Mitigating Risks of Past Damages
Renewing a Trademark Registration
Third Party Confidentiality
Inventors and Patent Analytics
Seeking Money from Investors
Confidential Information and Business Damage
Goal of a Value-Driven Patent Portfolio
Biologics Price Competition and Innovation Act
Picking a Trademark
Wasting Money on Low-Value Patents
"Claims" of a Patent
What Doesn't a Patent Provide?
Risks of OSS
What Engineers Can Learn from Patent Profile Analytics
Claim Maps and BioSimilars
First Item on IP To-Do List
NDAs and Customers
Tools for Auditing a Patent Portfolio
Patent Owner Rights
Litigation and BioSimilar Patenting
What Does an Audit Action Sheet Look Like?
IP Registration Density
Patent Ownership and Patent Profile Analytics
Trademark Filing Considerations
Approvals of BioSimilars in Europe
What Do I Give up in Getting My Patent?
Impact of US Hatch Waxman Act 1984
How do Patent Prosecution Services Vary in Value?
What is a Patent Portfolio?
By the Numbers Overview
Who Determines Substitution Factors?
Patent Profile Analytics and Managers
Low Risk Joint Ventures
How Should IP be Considered for Acquisition?
Considerations Before Hiring IP Council
Hiring Patent Council
How to Navigate BioSimilar Challenges
Assessing Executive Experience
Advantages of Registering a Trademark
Equal Value Patents
What is a BioSimilar?
4 Ways to Prepare your Patent Portfolio for Battle.
How is the Entire Patent Considered Prior Art?
Freedom to Operate
Consequences of Disclosing Confidential Information
Importance of Post-Grant Proceedings
What is a BioSimilar Product Under US Law?
Prior Art in Prosecution vs Prior Art in Litigation
High Risk Joint Ventures
Two Main Value Drivers
Trade Names vs Trademarks
FDA Guidelines for Demonstrating Biosimilarity
Secondary Meaning of a Trademark
The Advantage of Filing First
Signing an NDA
Improving Patent Portfolio Value
Freedom to Operate (FTO) Process
Value Management Lifecycle
Impact of Post-Grant Proceedings
Scope Concepts and Headnotes
Limiting Issues Defined in District Court
Downside of Static Budget Allocation for Patents
Value-Driven Patent Portfolio
Are BioSimilars Being Approved in the US?
"Wheres" - Audit Action Sheet
Freedom To Operate
Why Perform Risk Profile?
Patent Trial and Appeal Board
Freedom To Operate vs Clearance
Becoming a Patent Lawyer
How Should IP be Considered for Growth?
Date of First Use
Post-Grant Options and Grounds of Challenge
Effective Stay Strategy
Schwegman Lundberg & Woessner & Post Grant Trial Practice
What to Do When First Selecting a Mark
Cited Art Landscape
Biologics vs Small Molecules
Budgeting for Drafting and Prosecution
Factors That Make a Patent Valuable
Using Product Association with IP Assets
Discovering Annuity Information
Why Are Biologicals so Important?
Broad Patent Claim
Inventorship vs Ownership
Outside of Law
Purposes of a Trademark
Different Parts of a Patent Document
Qualifying for a Patent
Patent Portfolio and Budgets/Spending
Most Common Client Question
Intellectual Property Protection
Value Management and Risk Management
Joint Ventures and Dispute Resolution
Attorneys Not Understanding the Market
Consequences of a Poorly Drafted Patent
Segmenting a Portfolio
A Better Way to Allocate Patent Application Budgets
Patent Status Updates
Why Should Claims Not Be Read on the Prior Art?
Steps to Obtaining a Patent
Patent Strategy Considerations
Refused Trademark Recourse
Forms of Confidential Information
"How Much" - Audit Action Sheet
The Different Types of Marks
Determining Likelihood of Confusion
Why Do You Enjoy Being a Lawyer?
NDAs and Computer Codes
OSS Licensing Conditions
How Does the Knowledge Gap Worsen Over Time?
Evaluation Agreement and Computer Codes
How Much Does it Cost to Get a Patent?
Attributes of a Good Patent
What is a Trademark?
Naming Problems with BioSimilars
The Five Components of an Open Source Software Policy
How is Schwegman Lundberg & Woessner Different?
Portfolio Dashboard - Inventor Information
Interpretational Differences Between Prosecution and Litigation
Get Your Assignments Straight - Contribution of Owners
Intent of Patent Laws
Important Attributes to Being a Successful Patent Lawyer
"Whats" - Audit Action Sheet
Marking a Product
Implementing a Value-Driven Portfolio Process
Researching Competitors' IP
Do Narrow Patents Add Value to a Portfolio?
"Whens" - Audit Action Sheet
What Should a Company Patent?
Contractual Intellectual Property Rights
Patents and Practicing an Invention
Forward Citation Landscape
What Should a Company Understand at the End of an IP Audit?
Patent Examination Process
Domain Registration Considerations
Rebutting a Merely Descriptive Refusal
Post-Grant Options and Estoppel
Post-Grant Options and Cost
A Less Expensive Alternative
Patent Analytics and Competition
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Patent Profile Analytics and Researchers
Covered Business Method Review
What IP Should I Spend Money on First?
PTAB Final Argument Trial Dynamics
Reasons to Consider Joint Ventures
Audit Action Sheet
Cost of Registering a Trademark
Categories of Marks
Raising Good Prosecution Visibility
Independent Claim vs Dependent Claim
Joint Venture Ground Rules
Tracking Work History
How is Open Source Incorporated into Software?
Ideal Patent Strategy
Types of Intellectual Property Protection
BioSimilar Patenting Litigation Involving Large Amounts of Money
Claim Abstraction Theory
Infringement on the Rights of Other Patents
Process for Registering a Trademark in the United States
Trade Name Protection and Trademark Protection
Improperly Marked Product
The Case of the Joint Marketing Agreement Gone Bad
When is a House like a Patent?
Open Source Software
Repeating Competitor Audits
Common Law Trademark Rights
Joint Venture Pitfalls
Geographic Insight and Patent Profile Analytics
Joint Venture and Financial Agreements
Proper Way to Use a Trademark
Picking a Domain Name
Is There Still a Place for Traditional Re-Examination?
Open Source Initiative
Patent Profile Analytics and Engineers
Risks of Not Patenting
Should IP be Part of Our Business Plan?
Meet David Black
Importance of Getting a Patent
What Makes Schwegman, Lundberg & Woessner Different?
Auction Audit Sheet - Key Issues to Address
Why Is Executing an NDA Not Enough?
Infringing on Another Patent
Engineers Not Understanding Patents
Am I Required to Search for Prior Art?
How to Fix the Knowledge Gap
Is A United States Registered Trademark Effective in Other Countries?
PTAB Timing Trial Dynamics
How Long Does an FTO Take?
How Big Should My First Patent Be?
Merely Descriptive Refusal
Trademarks and Brand Value
Calculating New Investments
Challenges When Dealing with Patent Matters
Requirements to Receive a Patent
What is Prior Art?
Prior Art and Rejections
How to Remedy Unwanted Disclosure of Confidential Information
How is Open Source Software Enforced?
Impact of PTAB
Prior Art Challenge